We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$14.9B
AUM Growth
-$125M
Cap. Flow
+$602M
Cap. Flow %
4.04%
Top 10 Hldgs %
16.63%
Holding
1,195
New
6
Increased
170
Reduced
89
Closed
18

Top Buys

Rank Stock Value
1
UCB
United Community Banks
UCB
+$98.2M
2
FLS icon
Flowserve
FLS
+$86.8M
3
SPR
Spirit AeroSystems
SPR
+$82.2M
4
CTS icon
CTS Corp
CTS
+$70M
5
CRL icon
Charles River Laboratories
CRL
+$62.2M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$115M
2
MPWR icon
Monolithic Power Systems
MPWR
+$75.3M
3
EBS icon
Emergent Biosolutions
EBS
+$57.3M
4
ON icon
ON Semiconductor
ON
+$28.3M
5
SQM icon
Sociedad Química y Minera de Chile
SQM
+$20.1M

Sector Composition

Rank Sector Weight
1 Financials 20.5%
2 Industrials 19.89%
3 Technology 19.85%
4 Consumer Discretionary 10.32%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQT icon
751
EQT Corp
EQT
$33B
$5K ﹤0.01%
115
– –
EXPE icon
752
Expedia Group
EXPE
$35.2B
$5K ﹤0.01%
53
– –
FIVE icon
753
Five Below
FIVE
$12.1B
$5K ﹤0.01%
37
– –
FNF icon
754
Fidelity National Financial
FNF
$14B
$5K ﹤0.01%
138
– –
FOXA icon
755
Fox Class A
FOXA
$24.7B
$5K ﹤0.01%
175
– –
GDDY icon
756
GoDaddy
GDDY
$13.2B
$5K ﹤0.01%
76
– –
GLPI icon
757
Gaming and Leisure Properties
GLPI
$12.7B
$5K ﹤0.01%
104
– –
HRB icon
758
H&R Block
HRB
$5.61B
$5K ﹤0.01%
119
– –
HSIC icon
759
Henry Schein
HSIC
$9.7B
$5K ﹤0.01%
80
– –
INCY icon
760
Incyte
INCY
$24.9B
$5K ﹤0.01%
73
– –
INO icon
761
Inovio Pharmaceuticals
INO
$54M
$5K ﹤0.01%
229
– –
IPG
762
DELISTED
Interpublic Group of Companies
IPG
$5K ﹤0.01%
193
– –
IR icon
763
Ingersoll Rand
IR
$33B
$5K ﹤0.01%
126
– –
LDOS icon
764
Leidos
LDOS
$14.1B
$5K ﹤0.01%
55
– –
LEA icon
765
Lear
LEA
$7.33B
$5K ﹤0.01%
39
– –
LNC icon
766
Lincoln National
LNC
$8.8B
$5K ﹤0.01%
105
– –
MTCH icon
767
Match Group
MTCH
$9.17B
$5K ﹤0.01%
103
– –
NDSN icon
768
Nordson
NDSN
$16.4B
$5K ﹤0.01%
22
– –
OLN icon
769
Olin
OLN
$2.53B
$5K ﹤0.01%
109
– –
PARA
770
DELISTED
Paramount Global Class B
PARA
$5K ﹤0.01%
285
– –
PINS icon
771
Pinterest
PINS
$13.7B
$5K ﹤0.01%
221
– –
PLNT icon
772
Planet Fitness
PLNT
$4.43B
$5K ﹤0.01%
79
– –
RVTY icon
773
Revvity
RVTY
$12.7B
$5K ﹤0.01%
38
– –
SIRI icon
774
SiriusXM
SIRI
$10.4B
$5K ﹤0.01%
83
– –
SJM icon
775
J.M. Smucker
SJM
$13.1B
$5K ﹤0.01%
39
– –
29 30
31
32 33

Similar funds

JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

EARNEST Partners's Q3 2022 Portfolio in Review

As of Q3 2022, EARNEST Partners held 1,195 positions worth $14.9B, down 0.84% from $15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EARNEST Partners deployed $602M of net new capital in Q3 2022, opening 6 new positions and adding to 170 existing holdings. Its largest new stake was CTS Corp: 1,744,320 shares worth $72.7M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $115M trimmed.

  • EARNEST Partners's largest Q3 2022 buy was CTS Corp: 1,744,320 shares worth $72.7M.
  • EARNEST Partners added most to United Community Banks in Q3 2022, an estimated $98.2M increase.
  • EARNEST Partners's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $115M.
  • EARNEST Partners fully exited Emergent Biosolutions in Q3 2022, selling an estimated $57.3M.
  • EARNEST Partners's ten largest holdings make up 17% of its $14.9B portfolio in Q3 2022.
  • EARNEST Partners opened 6 new positions and closed 18 in Q3 2022.
  • EARNEST Partners's portfolio value fell 0.84% quarter-over-quarter to $14.9B.

Based on EARNEST Partners's 13F filing for Q3 2022, filed 14 Nov 2022.